RepliCel Life Sciences Inc. Their innovative cell therapy products are custom-made to restore cellular function, providing rejuvenation for aging or sun-damaged skin, hair regrowth, and tendon repair. Taking a leap forward in aesthetic treatment, RepliCel's next-generation dermal injection technology aims to revolutionize treatment outcomes in the field.

The company is committed to enhancing everyday lives through their cutting-edge solutions. RepliCel utilizes two unique cell therapy populations sourced from hair follicles, obtained from a small skin biopsy at the back of the patient's head. Additionally, they are developing a medical device that incorporates patent-protected technologies to improve patient injections.

Their current product lineup includes RCH-01, a cell therapy for pattern baldness, RCS-01, a cell therapy for aging or sun-damaged skin, RCT-01, a cell therapy for tendon degeneration, and DermaPrecise™, a next-generation dermal injection device. With an experienced team and a dedication to improving lives, RepliCel is at the forefront of regenerative medicine